Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Adrenal & Rare Endocrine Cancers

Anne-Paule Gimenez-Roqueplo

安-波尔·希梅内斯-罗克普洛

MD, PhD

🏢Hôpital Européen Georges-Pompidou, AP-HP(欧洲乔治·蓬皮杜医院,巴黎公立医院集团)🌐France

Professor of Genetics and Head of Molecular Genetics Laboratory遗传学教授兼分子遗传学实验室主任

52
h-index
3
Key Papers
2
Awards
3
Key Contributions

👥Biography 个人简介

Anne-Paule Gimenez-Roqueplo is a world leader in the genetics of pheochromocytoma and paraganglioma, having co-discovered SDHD and SDHB as hereditary paraganglioma susceptibility genes. She heads the French national PPGL network PGL.NET and co-chairs the international Genomics and Epigenomics of PPGL consortium.

Share:

🧪Research Fields 研究领域

Paraganglioma Genetics副神经节瘤遗传学
SDHB/SDHD MutationsSDHB/SDHD基因突变
Hereditary Endocrine Tumors遗传性内分泌肿瘤

🎓Key Contributions 主要贡献

SDH Gene Discovery

Co-discovered SDHD and SDHB germline mutations as causes of hereditary paraganglioma, establishing the role of mitochondrial complex II dysfunction in neuroendocrine tumorigenesis.

PPGL Genomics Consortium

Co-led international genomic studies defining the complete mutational landscape of PPGL, identifying novel susceptibility genes including TMEM127, MAX, and FH.

PGL.NET National Network

Founded and coordinates the French national PPGL registry PGL.NET, enabling systematic genotype-phenotype studies and standardized patient care across France.

Representative Works 代表性著作

[1]

Mutations in the SDHB Gene Are Associated with Extra-Adrenal and/or Malignant Phaeochromocytomas

Cancer Research (2003)

Established SDHB mutation as a key predictor of malignancy and extra-adrenal location in paraganglioma, transforming risk stratification.

[2]

Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma

Nature Genetics (2017)

Large-scale multi-omic TCGA analysis defining molecular clusters and driver alterations across the full PPGL spectrum.

[3]

SDHB Gene as a Major Contributor to the Malignant Phenotype in Paraganglioma

Journal of Clinical Endocrinology & Metabolism (2006)

Demonstrated SDHB as the dominant genetic risk factor for metastatic paraganglioma, guiding surveillance intensity decisions.

🏆Awards & Recognition 奖项与荣誉

🏆French Academy of Medicine Prize for Genetics
🏆Endocrine Society International Leadership Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 安-波尔·希梅内斯-罗克普洛 的研究动态

Follow Anne-Paule Gimenez-Roqueplo's research updates

留下邮箱,当我们发布与 Anne-Paule Gimenez-Roqueplo(Hôpital Européen Georges-Pompidou, AP-HP)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment